Tech Center 1600 • Art Units: 1633 1634
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17309403 | AAV VIRAL VECTORS AND USES THEREOF | Non-Final OA | NOVARTIS AG |
| 17430086 | MESENCHYMAL STEM CELL SHEET AND USE THEREOF | Final Rejection | BOE TECHNOLOGY GROUP CO., LTD. |
| 17612669 | MODIFIED VIRAL PARTICLES AND USES THEREOF | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18640282 | PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS | Final Rejection | The Curators of the University of Missouri |
| 18546746 | Transplantation of Liver Cells by Administration to the Biliary Tree of the Liver | Non-Final OA | Cambridge Enterprise Limited |
| 17998330 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | Final Rejection | The Trustees of the University of Pennsylvania |
| 17433195 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18035021 | LIVE CELL ASSAY FOR PROTEASE INHIBITION | Non-Final OA | Regents of the University of Minnesota |
| 17789314 | Method for Producing Serum for Culturing Mammalian Cells | Non-Final OA | NIPRO CORPORATION |
| 17268635 | PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES | Non-Final OA | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17260443 | PLURIPOTENT STEM CELL-DERIVED PLATE-SHAPED CARTILAGE AND METHOD FOR PRODUCING THE SAME | Final Rejection | KYOTO UNIVERSITY |
| 17425709 | ANUCLEATE CELL-DERIVED VACCINES | Final Rejection | STEMCELL TECHNOLOGIES CANADA INC. |
| 17612487 | METHODS OF CULTURING QUIESCENT HEMATOPOIETIC STEM CELLS AND TREATMENT METHODS | Final Rejection | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| 17309207 | REGENERATIVE ABSCOPAL EFFECTS | Non-Final OA | Figene, LLC |
| 17917198 | B7-H3 CHIMERIC ANTIGEN RECEPTORS | Non-Final OA | St. Jude Children's Research Hospital, Inc. |
| 16990185 | NON-HLA RESTRICTED T CELL RECEPTORS AND USES THEREOF | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 18258778 | METHOD FOR PRODUCING OLIGODENDROCYTES | Non-Final OA | Koji TANABE |
| 17434513 | RECOMBINANT VECTORS COMPRISING ARYLSULFATASE A AND THEIR USES IN STEM CELL THERAPY FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY | Non-Final OA | VERSITECH LIMITED |
| 18212404 | USE OF PROSTAGLANDIN E2 (PGE2)-PRIMED MESENCHYMAL STEM CELL (MSC) PRODUCT IN PREPARATION OF DRUG FOR TREATING LUNG INJURY (LI) | Non-Final OA | NANKAI UNIVERSITY |
| 18285180 | MEDIUM COMPOSITION FOR CULTURING MUSCLE STEM CELL COMPRISING CURCUMIN LONGA, GLYSIN, OR INSULIN FOR PROLIFERATION OF MUSCLE STEM CELL | Non-Final OA | DANAGREEN CO., LTD. |
| 17047945 | METHOD FOR MONITORING THE VIABILITY OF A GRAFT | Non-Final OA | HEMARINA |
| 16970216 | COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS V, INC. |
| 17628105 | METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS | Non-Final OA | NKARTA, INC. |
| 17997377 | METHOD TO PRODUCE T CELLS AND USES THEREOF | Non-Final OA | OSPEDALE SAN RAFFAELE S.R.L. |
| 17291658 | CARBON NANOTUBE COMPOSITE VECTOR HAVING SYNERGISTIC EFFECT OF PHOTOTHERMAL THERAPY AND GENE THERAPY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Non-Final OA | DALIAN MINZU UNIVERSITY |
| 17414425 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES | Final Rejection | Massachusetts Ear and Eye Infirmary |
| 17309030 | PROCESS FOR ENGINEERING TARGETED NANOPARTICLES | Final Rejection | University of North Texas Health Science Center |
| 17050794 | TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE KINASE | Non-Final OA | Seattie Children's Hospital d/b/a Seattle Children's Research Institute |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy